Fibronectin concentration in the plasma of patients with malignant and benign breast disease.

[1]  L. Puricelli,et al.  Serial analysis of fibronectin concentration in plasma of patients with benign and malignant breast diseases , 1986, Cancer.

[2]  L. Zardi,et al.  Fibronectin concentrations in pleural effusions of patients with malignant and non-malignant diseases. , 1984, Cancer letters.

[3]  D. Mosher.  Physiology of fibronectin. , 1984, Annual review of medicine.

[4]  L. Zardi,et al.  Increased plasma fibronectin concentrations in tumor bearing mice. , 1983, Cancer letters.

[5]  D. Mosher,et al.  Fibronectin concentration in plasma of patients with breast cancer, colon cancer, and acute leukemia , 1983, Cancer.

[6]  Akiyama Sk,et al.  Fibronectin in disease. , 1983, Monographs in pathology.

[7]  R. Hynes,et al.  Fibronectins: multifunctional modular glycoproteins , 1982, The Journal of cell biology.

[8]  R. Poisson,et al.  Biologic markers and breast cancer: A multiparametric study—1. Increased serum protein levels , 1982, Cancer.

[9]  A. Fountas,et al.  Plasma fibronectin in normal subjects and in various disease states. , 1981, Journal of clinical pathology.

[10]  T. Waalkes,et al.  Serum levels of fibronectin and a fibronectin-like DNA-binding protein in patients with various diseases. , 1980, Journal of the National Cancer Institute.

[11]  F. Blumenstock,et al.  Circulating immunoreactive and bioassayable opsonic plasma fibronectin during experimental tumour growth , 1980, British Journal of Cancer.

[12]  L. Zardi,et al.  Concentration of fibronectin in plasma of tumor-bearing mice and synthesis by Ehrlich ascites tumor cells. , 1979, Cancer research.

[13]  F. Blumenstock,et al.  Opsonic α2 Surface Binding Glycoprotein Therapy During Sepsis , 1978 .

[14]  D. Mosher,et al.  High molecular weight, cell surface-associated glycoprotein (fibronectin) lost in maglinant transformation , 1978 .

[15]  F. Blumenstock,et al.  Cryoprecipitate reversal of opsonic alpha2-surface binding glycoprotein deficiency in septic surgical and trauma patients. , 1978, Science.

[16]  Williams Em,et al.  Fibronectin concentration is decreased in plasma of severely ill patients with disseminated intravascular coagulation. , 1978 .

[17]  H. Bernard,et al.  Deficits in reticuloendothelial humoral control mechanisms in patients after trauma. , 1976, The Journal of trauma.

[18]  D. Mosher.  Changes in plasma could-insoluble globulin concentration during experimental Rocky Mountain spotted fever infection in rhesus monkeys. , 1976, Thrombosis research.

[19]  N. Heimburger,et al.  Factor-VIII-related antigen and cold-insoluble globulin in leukemias and carcinomas. , 1976, Haemostasis.

[20]  J. P. Jackson,et al.  Dimensions of humoral recognition factor depletion in carcinomatous patients. , 1972, Cancer research.

[21]  S. Siegel,et al.  Nonparametric Statistics for the Behavioral Sciences , 2022, The SAGE Encyclopedia of Research Design.

[22]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.